RI
ZYNE

RTW Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

RTW Investments’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-202,859
Closed -$2.54M – 43
2017
Q4 		$2.54M Buy
202,859
+2,859
+1% +$32.8K 0.42% 28
2017
Q3 		$1.67M Buy
+200,000
New +$2.11M 0.29% 24

Other funds holding ZYNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RTW Investments's ZYNE Position: Q1 2018 in Review

RTW Investments sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2018, closing a stake of 202,859 shares — an estimated $2.54M sold.

RTW Investments first reported a position in ZYNE in Q3 2017 and held it in 2 quarters. The position peaked at $2.54M in Q4 2017. 61 funds tracked by Wall St. Rank hold ZYNE as of Q1 2018.

  • RTW Investments reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2018 after selling out during the quarter.
  • RTW Investments sold 202,859 Zynerba Pharmaceuticals, Inc shares in Q1 2018, an estimated $2.54M.
  • RTW Investments first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2017 and held it in 2 quarters.
  • RTW Investments's Zynerba Pharmaceuticals, Inc position peaked at $2.54M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2018.

Based on RTW Investments's 13F filing for Q1 2018, filed 14 May 2018.